Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02820415
Other study ID # Trial1
Secondary ID
Status Completed
Phase N/A
First received June 24, 2016
Last updated June 30, 2016
Start date June 2014
Est. completion date December 2015

Study information

Verified date June 2016
Source Unità di Medicina della Riproduzione, Italy
Contact n/a
Is FDA regulated No
Health authority Italy: National Institute of Health
Study type Observational [Patient Registry]

Clinical Trial Summary

Oocyte accumulation by vitrification is a valid strategy to increase the number of available embryos for biopsy and the number of viable euploid embryos to transfer after preimplantation genetic testing.


Description:

In the present study, the investigators considered the hypothesis to accumulate vitrified oocytes with a view to increasing the number of oocytes for micro-injection and consequently the number of blastocyst to diagnose for patients with normal ovarian reserve and candidate for PGT. The partecipants were proposed to undergo several cycles of ovarian stimulation. In the first cycles, mature (metaphase II) oocytes were vitrified and consequently accumulated. In the last cycle, the freshly produced mature oocytes and the previously accumulated ones were micro-injected together with the same partner's semen sample. PGT was performed on blastocysts produced from the two sources of oocytes. The comprehensive chromosomal analysis of biopsied trophectoderm cells was performed using NGS technology. The number of available euploid blastocyst and the proportion of euploid/aneuploidy embryos from fresh and vitrified/warmed oocytes were compared. In conclusion the investigators evaluated the efficacy of oocyte accumulation by vitrification in increasing the number of available embryos for biopsy and the number of viable euploid embryos to transfer after PGT.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date December 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender Female
Age group 28 Years to 43 Years
Eligibility Inclusion Criteria:

- infertile women

- normal ovarian reserve

- with repeated implantation failure or reccurent miscarriage

- undergoing ICSI and asking to know the state of health of the embryos prior to embryo transfer

Study Design

Observational Model: Cohort


Related Conditions & MeSH terms

  • Increase the Number of Blastocyst to Biopsy for Preimplantation Genetic Testing

Intervention

Other:
chromosomal status of blastocysts from fresh and vitrified/warmed oocytes


Locations

Country Name City State
Italy Sandrine Chamayou Sant'agata Li Battiati

Sponsors (1)

Lead Sponsor Collaborator
Unità di Medicina della Riproduzione, Italy

Country where clinical trial is conducted

Italy, 

References & Publications (4)

Chamayou S, Alecci C, Ragolia C, Storaci G, Maglia E, Russo E, Guglielmino A. Comparison of in-vitro outcomes from cryopreserved oocytes and sibling fresh oocytes. Reprod Biomed Online. 2006 Jun;12(6):730-6. — View Citation

Chamayou S, Bonaventura G, Alecci C, Tibullo D, Di Raimondo F, Guglielmino A, Barcellona ML. Consequences of metaphase II oocyte cryopreservation on mRNA content. Cryobiology. 2011 Apr;62(2):130-4. doi: 10.1016/j.cryobiol.2011.01.014. Epub 2011 Jan 25. — View Citation

Chamayou S, Patrizio P, Storaci G, Tomaselli V, Alecci C, Ragolia C, Crescenzo C, Guglielmino A. The use of morphokinetic parameters to select all embryos with full capacity to implant. J Assist Reprod Genet. 2013 Jun;30(5):703-10. doi: 10.1007/s10815-013-9992-2. Epub 2013 Apr 13. — View Citation

Chamayou S, Romano S, Alecci C, Storaci G, Ragolia C, Palagiano A, Guglielmino A. Oocyte vitrification modifies nucleolar remodeling and zygote kinetics-a sibling study. J Assist Reprod Genet. 2015 Apr;32(4):581-6. doi: 10.1007/s10815-015-0446-x. Epub 2015 Feb 21. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary rate of euploidy in blastocyst from fresh and vitrified/warmed oocytes from fresh and vitrified/warmed oocytes 1 year Yes